Results for tag: "Insulin Glargine"

Insulin Glargine is a long-acting insulin analog used to treat diabetes mellitus, a metabolic disorder. It is used to control blood sugar levels in adults and children with type 1 diabetes and adults with type 2 diabetes. It is administered by subcutaneous injection and works by helping the body use glucose more efficiently. Insulin Glargine is a recombinant human insulin analog that is modified to reduce its solubility and prolong its action. It is available in both prefilled pens and vials. Insulin Glargine is a key drug in the Endocrine and Metabolic Disorders Drugs market. It is used to treat diabetes, a chronic condition that affects millions of people worldwide. It is an important part of diabetes management, helping to control blood sugar levels and reduce the risk of complications. Companies in the Insulin Glargine market include Sanofi, Eli Lilly, Novo Nordisk, Merck, and Boehringer Ingelheim. Show Less Read more